Annual report

Period2023-04-01 → 2024-03-31
Filed2024-06-20
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 154
MetricValuePeriodScopeSource row
Revenue¥1.03T2023-04-01 → 2024-03-31Cons.Net sales
Revenue¥1.02T2022-04-01 → 2023-03-31Cons.Net sales
Revenue¥926.1bn2021-04-01 → 2022-03-31dCons.Net sales (5-year summary)
Revenue¥836.5bn2020-04-01 → 2021-03-31dCons.Net sales (5-year summary)
Revenue¥853.7bn2019-04-01 → 2020-03-31dCons.Net sales (5-year summary)
Operating income¥13.5bn2023-04-01 → 2024-03-31Cons.Operating income
Operating income¥12.9bn2022-04-01 → 2023-03-31Cons.Operating income
Ordinary income¥15.6bn2023-04-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥9.1bn2022-04-01 → 2023-03-31Cons.Ordinary income
Ordinary income¥49.7bn2021-04-01 → 2022-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥53.7bn2020-04-01 → 2021-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥54.3bn2019-04-01 → 2020-03-31dCons.Ordinary income loss (5-year summary)
Profit before tax¥28.4bn2023-04-01 → 2024-03-31Cons.Income before income taxes
Profit before tax−¥1.5bn2022-04-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥10.6bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥17.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥23.2bn2021-04-01 → 2022-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥6.7bn2020-04-01 → 2021-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥25.3bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥13.6bn2023-04-01 → 2024-03-31Cons.Profit loss
Net income−¥15.8bn2022-04-01 → 2023-03-31Cons.Profit loss
Total assets¥1.25Tat 2024-03-31Cons.Assets
Total assets¥1.24Tat 2023-03-31Cons.Assets
Total assets¥1.21Tat 2022-03-31dCons.Total assets (5-year summary)
Total assets¥1.04Tat 2021-03-31dCons.Total assets (5-year summary)
Total assets¥1.00Tat 2020-03-31dCons.Total assets (5-year summary)
Total liabilities¥769.1bnat 2024-03-31Cons.Liabilities
Total liabilities¥791.3bnat 2023-03-31Cons.Liabilities
Net assets / equity¥481.9bnat 2024-03-31Cons.Net assets
Net assets / equity¥451.1bnat 2023-03-31Cons.Net assets
Net assets / equity¥464.8bnat 2022-03-31dCons.Net assets
Net assets / equity¥430.4bnat 2021-03-31dCons.Net assets (5-year summary)
Net assets / equity¥411.4bnat 2020-03-31dCons.Net assets (5-year summary)
Cash and deposits¥125.9bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥142.8bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥123.6bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥140.3bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥130.7bnat 2022-03-31dCons.Cash and cash equivalents
Cash & equivalents¥166.5bnat 2021-03-31dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥156.3bnat 2020-03-31dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥69.5bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥55.1bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥89.7bn2021-04-01 → 2022-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥107.7bn2020-04-01 → 2021-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥94.2bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥46.1bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥52.4bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥198.4bn2021-04-01 → 2022-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥79.6bn2020-04-01 → 2021-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥67.9bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥43.2bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities
Financing cash flow¥7.2bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities
Financing cash flow¥71.1bn2021-04-01 → 2022-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥20.9bn2020-04-01 → 2021-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥8.1bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥55.072023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-92.042022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥120.582021-04-01 → 2022-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-34.72020-04-01 → 2021-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥131.632019-04-01 → 2020-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥552023-04-01 → 2024-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥115.722021-04-01 → 2022-03-31dCons.Diluted earnings per share (5-year summary)
EPS (diluted)¥124.432019-04-01 → 2020-03-31dCons.Diluted earnings per share (5-year summary)
Net assets per share¥2,358.37at 2024-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥2,209.82at 2023-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥2,288.05at 2022-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥2,115.61at 2021-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥2,053.57at 2020-03-31dCons.Net assets per share (5-year summary)
Equity ratio36.3%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio34.2%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio36.4%at 2022-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio39.0%at 2021-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio39.3%at 2020-03-31dCons.Equity to asset ratio (5-year summary)
ROE2.4%2023-04-01 → 2024-03-31Cons.Rate of return on equity (5-year summary)
ROE-4.1%2022-04-01 → 2023-03-31Cons.Rate of return on equity (5-year summary)
ROE5.5%2021-04-01 → 2022-03-31dCons.Rate of return on equity (5-year summary)
ROE-1.7%2020-04-01 → 2021-03-31dCons.Rate of return on equity (5-year summary)
ROE6.3%2019-04-01 → 2020-03-31dCons.Rate of return on equity (5-year summary)
Employees21,834at 2024-03-31Cons.Number of employees
Employees22,484at 2023-03-31Cons.Number of employees
Employees21,815at 2022-03-31dCons.Number of employees
Employees21,090at 2021-03-31dCons.Number of employees
Employees20,075at 2020-03-31dCons.Number of employees
Revenue¥132.2bn2023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥140.8bn2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥139.4bn2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥110.0bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥124.4bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Operating income¥4.2bn2023-04-01 → 2024-03-31StandaloneOperating income
Operating income¥7.4bn2022-04-01 → 2023-03-31StandaloneOperating income
Ordinary income¥75.1bn2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income¥115.1bn2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥27.7bn2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥17.0bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥32.3bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥75.0bn2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Profit before tax−¥13.4bn2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Net income¥67.4bn2023-04-01 → 2024-03-31StandaloneProfit loss
Net income−¥16.1bn2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥36.1bn2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income−¥14.7bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income¥28.5bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Total assets¥663.2bnat 2024-03-31StandaloneAssets
Total assets¥626.7bnat 2023-03-31StandaloneAssets
Total assets¥638.8bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥559.5bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥559.3bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥370.0bnat 2024-03-31StandaloneLiabilities
Total liabilities¥390.1bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥293.2bnat 2024-03-31StandaloneNet assets
Net assets / equity¥236.7bnat 2023-03-31StandaloneNet assets
Net assets / equity¥264.9bnat 2022-03-31dStandaloneNet assets
Net assets / equity¥239.3bnat 2021-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥256.6bnat 2020-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥6.2bnat 2024-03-31StandaloneCash and deposits
Cash and deposits¥50.6bnat 2023-03-31StandaloneCash and deposits
EPS (basic)¥350.362023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-83.62022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥188.162021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-76.422020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥148.52019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥349.932023-04-01 → 2024-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥180.592021-04-01 → 2022-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥140.382019-04-01 → 2020-03-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥302023-04-01 → 2024-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥402022-04-01 → 2023-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥552021-04-01 → 2022-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥502020-04-01 → 2021-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥602019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥1,521.24at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,228.24at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,375.63at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,243.18at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,333.56at 2020-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio44.2%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio37.7%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio41.4%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio42.7%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio45.8%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE25.5%2023-04-01 → 2024-03-31StandaloneRate of return on equity (5-year summary)
ROE-6.4%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE14.4%2021-04-01 → 2022-03-31dStandaloneRate of return on equity (5-year summary)
ROE-5.9%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
ROE11.3%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued197,953,707at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued197,953,707at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued197,953,707at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued197,953,707at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued197,953,707at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees2,829at 2024-03-31StandaloneNumber of employees
Employees2,874at 2023-03-31StandaloneNumber of employees
Employees2,890at 2022-03-31dStandaloneNumber of employees
Employees2,880at 2021-03-31dStandaloneNumber of employees
Employees2,819at 2020-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 76
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentscapex2023-04-01 → 2024-03-31¥7.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2023-04-01 → 2024-03-31¥4.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2024-03-311928 pure
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2024-03-31¥59.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2024-03-31¥54.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2024-03-31¥4.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2024-03-31¥134.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2024-03-31−¥751m
Healthcarereportable segmentcapex2023-04-01 → 2024-03-31¥13.2bn
Healthcarereportable segmentdepreciation2023-04-01 → 2024-03-31¥26.0bn
Healthcarereportable segmentemployeesat 2024-03-312835 pure
Healthcarereportable segmentrevenue2023-04-01 → 2024-03-31¥144.8bn
Healthcarereportable segmentrevenue external2023-04-01 → 2024-03-31¥144.7bn
Healthcarereportable segmentrevenue intersegment2023-04-01 → 2024-03-31¥64m
Healthcarereportable segmentsegment assetsat 2024-03-31¥218.7bn
Healthcarereportable segmentsegment profit2023-04-01 → 2024-03-31¥7.3bn
Materialreportable segmentcapex2023-04-01 → 2024-03-31¥37.7bn
Materialreportable segmentdepreciation2023-04-01 → 2024-03-31¥37.3bn
Materialreportable segmentemployeesat 2024-03-3110051 pure
Materialreportable segmentrevenue2023-04-01 → 2024-03-31¥450.0bn
Materialreportable segmentrevenue external2023-04-01 → 2024-03-31¥439.7bn
Materialreportable segmentrevenue intersegment2023-04-01 → 2024-03-31¥10.3bn
Materialreportable segmentsegment assetsat 2024-03-31¥590.6bn
Materialreportable segmentsegment profit2023-04-01 → 2024-03-31−¥6.2bn
—segment totalcapex2023-04-01 → 2024-03-31¥57.8bn
—segment totaldepreciation2023-04-01 → 2024-03-31¥71.8bn
—segment totalrevenue2023-04-01 → 2024-03-31¥997.6bn
—segment totalrevenue external2023-04-01 → 2024-03-31¥977.9bn
—segment totalrevenue intersegment2023-04-01 → 2024-03-31¥19.7bn
—segment totalsegment assetsat 2024-03-31¥1.10T
—segment totalsegment profit2023-04-01 → 2024-03-31¥22.8bn
Total Of Reportable Segments And Otherssegment totalcapex2023-04-01 → 2024-03-31¥65.5bn
Total Of Reportable Segments And Otherssegment totaldepreciation2023-04-01 → 2024-03-31¥76.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2024-03-31¥1.06T
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2024-03-31¥1.03T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2024-03-31¥24.4bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2024-03-31¥1.23T
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2024-03-31¥22.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentscapex2022-04-01 → 2023-03-31¥4.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2022-04-01 → 2023-03-31¥3.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2023-03-31¥54.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2023-03-31¥49.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2023-03-31¥5.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2023-03-31¥110.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2023-03-31−¥1.5bn
Healthcarereportable segmentcapex2022-04-01 → 2023-03-31¥8.6bn
Healthcarereportable segmentdepreciation2022-04-01 → 2023-03-31¥25.9bn
Healthcarereportable segmentrevenue2022-04-01 → 2023-03-31¥150.6bn
Healthcarereportable segmentrevenue external2022-04-01 → 2023-03-31¥150.6bn
Healthcarereportable segmentrevenue intersegment2022-04-01 → 2023-03-31¥0
Healthcarereportable segmentsegment assetsat 2023-03-31¥224.8bn
Healthcarereportable segmentsegment profit2022-04-01 → 2023-03-31¥25.2bn
Materialreportable segmentcapex2022-04-01 → 2023-03-31¥42.0bn
Materialreportable segmentdepreciation2022-04-01 → 2023-03-31¥33.0bn
Materialreportable segmentrevenue2022-04-01 → 2023-03-31¥448.6bn
Materialreportable segmentrevenue external2022-04-01 → 2023-03-31¥438.7bn
Materialreportable segmentrevenue intersegment2022-04-01 → 2023-03-31¥9.9bn
Materialreportable segmentsegment assetsat 2023-03-31¥558.0bn
Materialreportable segmentsegment profit2022-04-01 → 2023-03-31−¥21.3bn
—segment totalcapex2022-04-01 → 2023-03-31¥57.6bn
—segment totaldepreciation2022-04-01 → 2023-03-31¥66.6bn
—segment totalrevenue2022-04-01 → 2023-03-31¥988.3bn
—segment totalrevenue external2022-04-01 → 2023-03-31¥969.4bn
—segment totalrevenue intersegment2022-04-01 → 2023-03-31¥18.9bn
—segment totalsegment assetsat 2023-03-31¥1.06T
—segment totalsegment profit2022-04-01 → 2023-03-31¥21.7bn
Total Of Reportable Segments And Otherssegment totalcapex2022-04-01 → 2023-03-31¥61.6bn
Total Of Reportable Segments And Otherssegment totaldepreciation2022-04-01 → 2023-03-31¥70.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2023-03-31¥1.04T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2023-03-31¥1.02T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2023-03-31¥23.9bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-03-31¥1.17T
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2023-03-31¥20.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2024-03-31588 pure
Healthcarereportable segmentemployeesat 2024-03-3155 pure
Materialreportable segmentemployeesat 2024-03-311675 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 2,047
ItemContextValueUnit
Interest and dividends income ope cfCurrentYearDuration-3728000000JPY
Interest expenses ope cfPrior1YearDuration7084000000JPY
Interest expenses ope cfCurrentYearDuration10782000000JPY
Equity in earnings losses of affiliates ope cfPrior1YearDuration1105000000JPY
Equity in earnings losses of affiliates ope cfCurrentYearDuration-7336000000JPY
Loss gain on valuation of derivatives ope cfPrior1YearDuration-5518000000JPY
Loss gain on valuation of derivatives ope cfCurrentYearDuration-8222000000JPY
Loss gain on sales and retirement of noncurrent assets ope cfPrior1YearDuration-4030000000JPY
Loss gain on sales and retirement of noncurrent assets ope cfCurrentYearDuration1199000000JPY
Loss gain on sales of investment securities ope cfPrior1YearDuration-5468000000JPY
Loss gain on sales of investment securities ope cfCurrentYearDuration-11737000000JPY
Loss gain on valuation of investment securities ope cfPrior1YearDuration3703000000JPY
Loss gain on valuation of investment securities ope cfCurrentYearDuration371000000JPY
Insurance income ope cfPrior1YearDuration-JPY
Insurance income ope cfCurrentYearDuration-12544000000JPY
Subsidy income ope cfPrior1YearDuration-JPY
Subsidy income ope cfCurrentYearDuration-1639000000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YearDuration16528000000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYearDuration-6510000000JPY
Decrease increase in inventories ope cfPrior1YearDuration-26548000000JPY
Decrease increase in inventories ope cfCurrentYearDuration-21611000000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YearDuration-3055000000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYearDuration-11187000000JPY
Other net ope cfPrior1YearDuration7696000000JPY
Other net ope cfCurrentYearDuration9867000000JPY
Subtotal ope cfPrior1YearDuration79712000000JPY
Subtotal ope cfCurrentYearDuration50003000000JPY
Interest and dividends income received ope cf inv cfPrior1YearDuration9409000000JPY
Interest and dividends income received ope cf inv cfCurrentYearDuration16772000000JPY
Interest expenses paid ope cf fin cfPrior1YearDuration-6836000000JPY
Interest expenses paid ope cf fin cfCurrentYearDuration-10749000000JPY
Proceeds from insurance income ope cfPrior1YearDuration-JPY
Proceeds from insurance income ope cfCurrentYearDuration12544000000JPY
Proceeds from subsidy ope cfPrior1YearDuration-JPY
Proceeds from subsidy ope cfCurrentYearDuration1639000000JPY
Income taxes paid ope cfPrior1YearDuration-27199000000JPY
Income taxes paid ope cfCurrentYearDuration-758000000JPY
Net cash provided by used in operating activitiesPrior1YearDuration55086000000JPY
Net cash provided by used in operating activitiesCurrentYearDuration69451000000JPY
Purchase of property plant and equipment inv cfPrior1YearDuration-51512000000JPY
Purchase of property plant and equipment inv cfCurrentYearDuration-58112000000JPY
Proceeds from sales of property plant and equipment inv cfPrior1YearDuration5908000000JPY
Proceeds from sales of property plant and equipment inv cfCurrentYearDuration1228000000JPY
Purchase of intangible assets inv cfPrior1YearDuration-6224000000JPY
Purchase of intangible assets inv cfCurrentYearDuration-6930000000JPY
Purchase of investment securities inv cfPrior1YearDuration-4462000000JPY
Purchase of investment securities inv cfCurrentYearDuration-5432000000JPY
Proceeds from sales of investment securities inv cfPrior1YearDuration7491000000JPY
Proceeds from sales of investment securities inv cfCurrentYearDuration27325000000JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation inv cfPrior1YearDuration-675000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2024-03-31pass
balance sheet identitynon_consolidated 2023-03-31pass rounding
balance sheet identitynon_consolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass